perioperative immunotherapy for resectable nsclc: evaluating approved and emerging approaches
Published 2 months ago • 13 plays • Length 5:30Download video MP4
Download video MP3
Similar videos
-
5:30
tailoring your perioperative immunotherapy approach for resectable nsclc
-
5:00
when adjuvant immunotherapy for resectable nsclc may be the better approach
-
43:46
realizing the promise of perioperative immunotherapy in resectable nsclc
-
48:44
neoadjuvant, adjuvant, or both: individualized perioperative immunotherapy in resectable nsclc
-
49:11
how to integrate perioperative immunotherapy into multimodal treatment plans in resectable nsclc
-
53:19
improving survival and cure rates in resectable nsclc with perioperative immunotherapy
-
28:23
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
4:00
predicting response to neoadjuvant and perioperative chemoimmunotherapy
-
1:01:46
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
39:06
unleashing the potential of perioperative immunotherapy in resectable nsclc
-
32:52
immunotherapy for early-stage, resectable nsclc: from clinical trial data to guidelines
-
0:58
adherence & outcomes of neoadjuvant immunotherapy in resectable nsclc
-
4:22
dr awad on the fda approval of perioperative nivolumab for resectable nsclc
-
3:16
perioperative therapies in nsclc
-
2:56
perioperative immunotherapy and surgery for treating msi-high esophagogastric tumors
-
1:08:00
has immunotherapy brought us to an inflection point in the management of stage i-iii nsclc?
-
5:15
integrating perioperative immunotherapy strategies in nsclc
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
4:40
"neotorch study: perioperative toripalimab chemotherapy vs. chemotherapy in resectable nsclc |crsf